[The incidence of infection in tumor and eye fluid system, and specific humoral immunity to herpes viruses in patients with uveal melanoma].

Autor: Svetlova EV; Helmholtz Scientific Medical Research Center for Ophthalmic Diseases., Balatskaya NV; Helmholtz Scientific Medical Research Center for Ophthalmic Diseases., Saakyan SV; Helmholtz Scientific Medical Research Center for Ophthalmic Diseases., Zharov AA; Helmholtz Scientific Medical Research Center for Ophthalmic Diseases., Krichevskaya GI; Helmholtz Scientific Medical Research Center for Ophthalmic Diseases., Svirina IV; Helmholtz Scientific Medical Research Center for Ophthalmic Diseases., Izmailova NS; Helmholtz Scientific Medical Research Center for Ophthalmic Diseases., Myakoshina EB; Helmholtz Scientific Medical Research Center for Ophthalmic Diseases.

Publikováno v: Voprosy virusologii [Vopr Virusol] 2023 Mar 11; Vol. 68 (1), pp. 37-44. Date of Electronic Publication: 2023 Mar 11.

Features of Local Expression of Genes of Immune Response Cytokines and Trophic and Vasoregulatory Factors in Modeling of Retinal Pigment Epithelium Atrophy.

Autor: Neroeva NV; Helmholtz National Medical Research Center of Eye Diseases, Ministry of Health of the Russian Federation, Moscow, Russia., Balatskaya NV; Helmholtz National Medical Research Center of Eye Diseases, Ministry of Health of the Russian Federation, Moscow, Russia., Neroev VV; Helmholtz National Medical Research Center of Eye Diseases, Ministry of Health of the Russian Federation, Moscow, Russia., Svetlova EV; Helmholtz National Medical Research Center of Eye Diseases, Ministry of Health of the Russian Federation, Moscow, Russia., Ryabinа MV; Helmholtz National Medical Research Center of Eye Diseases, Ministry of Health of the Russian Federation, Moscow, Russia., Ilyukhin PA; Helmholtz National Medical Research Center of Eye Diseases, Ministry of Health of the Russian Federation, Moscow, Russia., Karmokova AG; Helmholtz National Medical Research Center of Eye Diseases, Ministry of Health of the Russian Federation, Moscow, Russia. asyakarma17@gmail.com.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2022 Feb; Vol. 172 (4), pp. 453-459. Date of Electronic Publication: 2022 Feb 17.

Immunological monitoring for prediction of clinical response to antitumor vaccine therapy.

Autor: Mikhaylova IN; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Shubina IZ; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Chkadua GZ; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Petenko NN; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Morozova LF; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Burova OS; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Beabelashvili RS; Laboratory of Genetic Engineering, Institute of Experimental Cardiology, Russian Cardiological Research and Production Complex, Moscow, Russia., Parsunkova KA; Diagnostic Laboratory Clinical Center 'Optimum', Sochi, Russia., Balatskaya NV; Department of Immunology and Virology, Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia., Chebanov DK; RUDN University, Moscow, Russia., Pospelov VI; 'Genetic Technologies and Analyses', Moscow, Russia., Nazarova VV; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Vihrova AS; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Cheremushkin EA; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Molodyk AA; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Kiselevsky MV; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Demidov LV; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.

Publikováno v: Oncotarget [Oncotarget] 2018 May 11; Vol. 9 (36), pp. 24381-24390. Date of Electronic Publication: 2018 May 11 (Print Publication: 2018).